“…In the brain, this enzyme is be lieved to regulate the concentrations of monoamine neurotransmitters in monoaminergic neurons [1]. Studies with multiple substrates and selective inhibitors have pro vided much evidence for the existence of two types (A and B) of MAO in rodent brain, liver and other tissues [1,11,12,28]. Type A preferentially deaminates serotonin, ad renaline and noradrenaline, and is more sen sitive to inhibition by clorgyline [1,2,11,12,17], while type B deaminates benzylamine and /S-phenylethylaminc and is more sensi tive to inhibition by dcprenyl [1,11,12,17,20,32], At present, two hypotheses concern ing the molecular nature of the two types of MAO activities have been proposed [1,11,12,28].…”